References
- Bennett M. L., Jackson J. M., Jorizzo J. L., Fleischer AB J. r., White W. L., Callen J. P. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000; 79: 37–46
- Holt P. J. A., Davies M. G., Saunders K. C., Nuki G. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 1980; 59: 114–33
- Powell F. C., Schroeter A. L., Su W. P., Perry H. O. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173–86
- Keane F. M., MacFarlane C. S., Munn S. E., Higgins E. M. Pyoderma gangrenosum and hepatitis C virus infection. Br J Dermatol 1998; 139: 924–5
- Daniels N. H., Callen J. P. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. Arch Dermatol 2004; 140: 1427–9
- Moschella S. L. Neutrophilic dermatosis. Dermatology, J. L Bolognia, J. L Jorizzo, R. P Rapini. Mosby, St Louis 2003, In
- Su W. P., Davis M. D., Weenig R. H., Powell F. C., Perry H. O. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004; 43: 790–800
- Thiers B. H. Pyoderma gangrenosum. Cutaneous medicine and surgery, K. A Arndt, P. E LeBoit, J. K Robinson, B. U Wintroub. WB Saunders, Philadelphia 1996, In
- Lebbe C., Moulonguet‐Michau I., Perrin P., Blanc F., Frija J., Civatte J. Steroid‐responsive pyoderma gangrenosum with vulvar and pulmonary involvement. J Am Acad Dermatol 1922; 27: 623–5
- http://www.wyeth.com/content/ShowLabeling.asp?id=101.
- Magliocco M. A., Gottlieb A. B. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. J Am Acad Dermatol 2004; 51: 580–4
- Scheinfeld N. The medical uses and side effects of etanercept with a focus on cutaneous disease. J Drugs Dermatol 2004; 3: 653–9